Scholarlink

<p>Non-motor symptoms (NMS) in Parkinson’s disease (PD) significantly impact quality of life, especially in later stages. REM sleep behavior disorder (RBD) affects approximately 42% of all PD patients and frequently precedes motor PD symptoms. RBD is linked to increased rates of depression and cognitive decline. This study explores how early RBD can predict the development of NMS profiles in patients, comparing those with and without early RBD. We identified a unique NMS profile associated with early RBD. These patients had a higher rate of cognitive impairment (M<sup>2</sup> = 326.84, <i>p</i> &lt; 0.001), apathy (M<sup>2</sup> = 332.93, <i>p</i> &lt; 0.001), hallucinations (M<sup>2</sup> = 480.05, <i>p</i> &lt; 0.001), depression (M<sup>2</sup> = 480.05, <i>p</i> &lt; 0.0001), anxiety (corrected <i>p</i> &lt; 0.01), impulse control disorders (M<sup>2</sup> = 77.577, <i>p</i> &lt; 0.001), and autonomic dysfunction (F = 251.8, <i>p</i> &lt; 0001). A survival analysis revealed an association between early RBD and faster progression to cognitive impairment. These NMS profiles may play a critical role in stratifying patients for targeted interventions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clinically probable RBD is an early predictor of malignant non-motor Parkinson’s disease phenotypes

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年1月29日

查看全文
  • Alfonso Enrique Martinez-Nunez,
  • Hunter Hutchinson,
  • Patricia Coutinho,
  • Filipe Pereira Sarmento,
  • Venkat Srikar Lavu,
  • Qingqi Yuan,
  • Jagan Mohan Reddy Dwarampudi,
  • Aysegul Gunduz,
  • Gregory M. Pontone,
  • Michael S. Okun,
  • Joshua K. Wong

摘要

Non-motor symptoms (NMS) in Parkinson’s disease (PD) significantly impact quality of life, especially in later stages. REM sleep behavior disorder (RBD) affects approximately 42% of all PD patients and frequently precedes motor PD symptoms. RBD is linked to increased rates of depression and cognitive decline. This study explores how early RBD can predict the development of NMS profiles in patients, comparing those with and without early RBD. We identified a unique NMS profile associated with early RBD. These patients had a higher rate of cognitive impairment (M2 = 326.84, p < 0.001), apathy (M2 = 332.93, p < 0.001), hallucinations (M2 = 480.05, p < 0.001), depression (M2 = 480.05, p < 0.0001), anxiety (corrected p < 0.01), impulse control disorders (M2 = 77.577, p < 0.001), and autonomic dysfunction (F = 251.8, p < 0001). A survival analysis revealed an association between early RBD and faster progression to cognitive impairment. These NMS profiles may play a critical role in stratifying patients for targeted interventions.